Nasdaq:US$13.35 (+0.09) | HKEX:HK$20.72 (+0.00) | AIM:£2.04 (+0.02)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models